Related Experiment Videos
Leukaemia cutis and leukaemic vasculitis
1Department of Oncology, Cukurova University Faculty of Medicine, 01330 BalcalAdana, Turkey. sepay@mail.cu.edu.tr
The British Journal of Dermatology
|November 9, 2000
Summary
Leukaemia cutis (LC) and leukaemic vasculitis (LV) are rare but significant indicators of hematologic malignancy. These conditions often signal a poor prognosis, necessitating further research into their pathogenesis.
Area of Science:
- Dermatology
- Hematology
- Oncology
Background:
- Leukaemia cutis (LC) and leukaemic vasculitis (LV) are uncommon but significant manifestations of hematologic malignancy.
- These conditions represent important clinical features requiring detailed evaluation.
Purpose of the Study:
- To evaluate the clinicopathological features of patients with leukaemia cutis and leukaemic vasculitis.
- To understand the clinical presentation and prognostic implications of these rare conditions.
Main Methods:
- Retrospective study of 34 patients diagnosed with leukaemia cutis.
- Analysis of patient data including underlying hematologic malignancy, lesion characteristics, and presence of vasculitis.
Main Results:
- Leukaemia cutis presented with diverse cutaneous lesions, including erythematous, maculopapular, nodular, and necrotic forms.
- Leukaemic vasculitis (LV) was detected in 24 patients, with high-grade LV (16 patients) associated with higher white blood cell counts and aggressive clinical course.
- Unique lesion localizations were observed at sites of prior varicella zoster virus infection and cutaneous leishmaniasis.
Conclusions:
- Leukaemia cutis and particularly leukaemic vasculitis are indicators of poor prognosis in patients with hematologic malignancies.
- Further research is needed to elucidate the pathogenesis of LC and LV, focusing on factors like adhesion molecules and angiogenic factors.